HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincent Jarlier Selected Research

DNA Gyrase

2/2013Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.
8/2010Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
9/2006First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.
4/2004Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincent Jarlier Research Topics

Disease

21Tuberculosis (Tuberculoses)
01/2020 - 10/2003
12Infections
08/2019 - 10/2002
9Buruli Ulcer
01/2020 - 10/2002
8Leprosy (Hansen's Disease)
01/2020 - 01/2002
3Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2017 - 11/2006
3Extensively Drug-Resistant Tuberculosis
03/2015 - 08/2010
2Nontuberculous Mycobacterium Infections
03/2014 - 02/2011
1Sepsis (Septicemia)
11/2021
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Chronic Renal Insufficiency
01/2019
1Enterobacteriaceae Infections
01/2015
1Ventilator-Associated Pneumonia
01/2014
1HIV Infections (HIV Infection)
06/2012
1Persistent Infection
01/2012
1Cystic Fibrosis (Mucoviscidosis)
02/2011
1Inflammation (Inflammations)
01/2009
1Endophthalmitis (Ophthalmia)
01/2009
1Body Weight (Weight, Body)
06/2008
1Human Influenza (Influenza)
10/2006
1Multibacillary Leprosy
01/2002

Drug/Important Bio-Agent (IBA)

17Rifampin (Rifampicin)FDA LinkGeneric
01/2020 - 01/2002
9Pharmaceutical PreparationsIBA
12/2018 - 06/2008
9FluoroquinolonesIBA
01/2017 - 01/2006
8Streptomycin (Streptomycin Sulfate)FDA Link
01/2020 - 02/2007
7bedaquiline (R207910)IBA
01/2020 - 01/2005
6Clarithromycin (Biaxin)FDA LinkGeneric
01/2020 - 10/2002
6Moxifloxacin (Avelox)FDA Link
01/2020 - 10/2007
6Anti-Bacterial Agents (Antibiotics)IBA
08/2019 - 05/2007
6Isoniazid (Ftivazide)FDA LinkGeneric
06/2012 - 10/2003
5Amikacin (A.M.K)FDA LinkGeneric
01/2017 - 10/2002
4DNA GyraseIBA
02/2013 - 04/2004
4DNA (Deoxyribonucleic Acid)IBA
02/2013 - 09/2006
4QuinolonesIBA
02/2013 - 04/2004
3Ofloxacin (Ofloxacine)FDA LinkGeneric
03/2015 - 01/2002
3DapsoneFDA Link
11/2013 - 01/2006
3AminoglycosidesIBA
11/2010 - 02/2007
2PyrazinamideFDA LinkGeneric
01/2020 - 01/2005
2rifapentine (Priftin)FDA Link
01/2020 - 06/2008
2AcidsIBA
01/2015 - 10/2002
2Meropenem (Merrem)FDA LinkGeneric
01/2014 - 06/2011
2ImipenemFDA Link
01/2014 - 06/2011
2EnzymesIBA
09/2012 - 03/2009
2DiarylquinolinesIBA
09/2009 - 01/2009
1Methicillin (Metin)FDA Link
11/2021
1N 30IBA
01/2020
1Clofazimine (Lamprene)FDA Link
01/2020
1CreatinineIBA
01/2019
1Colistin (Coly-Mycin)FDA Link
01/2019
1Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA
12/2018
1Levofloxacin (Levaquin)FDA Link
01/2017
1KanamycinFDA Link
01/2017
1Capreomycin (Capastat)FDA Link
01/2017
1beta-Lactamases (beta-Lactamase)IBA
01/2015
1Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
03/2014
1DoripenemFDA Link
01/2014
1Third Generation CephalosporinsIBA
12/2013
14-hydroxyphenylisopropylarterenol (CC 25)IBA
02/2013
1VaccinesIBA
02/2012
1Ertapenem (Invanz)FDA Link
06/2011
1Carbapenems (Carbapenem Antibiotics)IBA
06/2011
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
06/2011
1Catalytic DNA (Deoxyribozyme)IBA
08/2010
1Ethambutol (Myambutol)FDA LinkGeneric
05/2010
1Cyclic PeptidesIBA
05/2010
1Oseltamivir (Tamiflu)FDA Link
10/2006
1Dihydropteroate Synthase (Dihydropteroate Synthetase)IBA
01/2006
1Pipemidic Acid (Palin)IBA
04/2004
1Gatifloxacin (Zymar)FDA Link
04/2004
1Proteins (Proteins, Gene)FDA Link
04/2004
1Nalidixic AcidFDA Link
04/2004
1sparfloxacin (AT 4140)FDA Link
10/2002

Therapy/Procedure

3Injections
01/2020 - 06/2009
3Therapeutics
09/2013 - 01/2009
2Duration of Therapy
02/2007 - 11/2006
1Long-Term Care
01/2015
1Combination Drug Therapy (Combination Chemotherapy)
02/2012
1Drug Therapy (Chemotherapy)
02/2012
1Mesotherapy
06/2009
1Lasers (Laser)
01/2009
1Chemoprevention
10/2006